ANGIOCLAST
angioClast is a Cambridge biotech startup comitted to transform cancer research. Through the application of de novo markers of cancer blood vessels, angioClast strives to develop and revolutionize the treatment and diagnosis of various cancer types.
ANGIOCLAST
Industry:
Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.angioclast.co.uk
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Weebly
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Current Employees Featured
Minaam Abbas
Minaam Abbas Chief Operating Officer @ angioClast Chief Operating Officer 2016-12-01
Juba Tsuladze
Juba Tsuladze CEO & Co-founder @ angioClast CEO & Co-founder
Founder
Juba Tsuladze
Minaam Abbas
Investors List
Pitch@Palace
Pitch@Palace investment in Non Equity Assistance - angioClast
Newest Events participated
Participated in Pitch@Palace 5.0
on 2016-03-07 as exhibitor
Official Site Inspections
http://www.angioclast.co.uk
- Host name: cld9-0334-8791.cpanel.ge
- IP address: 195.69.143.142
- Location: Georgia
- Latitude: 41.9913
- Longitude: 43.4753
- Timezone: Asia/Tbilisi
Loading ...